Find Academic Supervisors

James Warwick Bisley is a Professor of Neurobiology in the School of Medicine at the University of California Los Angeles (UCLA). His research focuses on the neural mechanisms underlying visual attention, eye movement control, and spatial processing in the brain. Dr. Bisley has made significant contributions to understanding how the brain guides attention and eye movements during visual search tasks, particularly through his work on the lateral intraparietal area (LIP) and frontal eye field (FEF). Dr. Bisley earned his PhD in Neuroscience from the University of Melbourne in December 1997. His research has been consistently supported by NIH funding, including R01 grants R01EY027968 (2018-2022) and R01EY019273 (2008-2019), where he served as Principal Investigator investigating neural processing in covert attention and the neural mechanisms underlying the guidance of visual attention. His research interests span visual attention, neural remapping, eye movement control, and the neural basis of spatial cognition. Dr. Bisley's work has demonstrated how brain areas like LIP and FEF contribute to visual attention and eye movement planning through the creation of priority maps. His recent publications show an expansion into haptic feedback applications in robotic surgery, demonstrating the translational potential of basic neuroscience research to improve surgical technologies. Dr. Bisley's publication record from 2016-2022 reveals a dual research focus: approximately half of his work continues to explore fundamental mechanisms of visual attention and neural processing, while the other half applies these principles to enhance robotic surgical systems through improved haptic feedback and tactile sensing. This interdisciplinary approach bridges cognitive neuroscience with biomedical engineering to address practical challenges in medical technology. Neural processing in covert attention (NIH R01EY027968, 2018-2022) The Neural Mechanisms Underlying the Guidance of Visual Attention (NIH R01EY019273, 2008-2019) Dr. Bisley has established himself as a leading researcher in visual neuroscience, with numerous highly cited publications in top journals including Journal of Neuroscience, Cerebral Cortex, and Proceedings of the National Academy of Sciences. His collaborative work spans multiple disciplines, connecting basic neuroscience with engineering applications to create innovative solutions for medical challenges.

• Visual Attention
• Neural Processing
• Eye Movement Control
• +6 more

Olga Vitek is a Professor at Northeastern University's Khoury College of Computer Sciences, with affiliated faculty status in the Department of Chemistry and Chemical Biology. Her research bridges statistical science and machine learning with mass spectrometry-based proteomics and systems biology, focusing on developing open-source software tools like MSstats and Cardinal for quantitative proteomic analyses and imaging. Education: PhD in Statistics (Purdue University), Postdoc at the Ruedi Aebersold Lab (Institute for Systems Biology) Leadership: Director of the Barnett Institute for Chemical and Biological Analysis Her work emphasizes: Statistical experimental design Signal detection in complex mass spectrometry data Causal inference in biomolecular networks Reproducible computational infrastructure Recent publications highlight advancements in quantitative proteomics , mass spectrometry imaging , and causal modeling , with applications spanning cancer research, immunology, and clinical diagnostics. Notable trends include deep learning integration for image analysis and open-source tool development for scalable, transparent workflows. Scientific accolades: Elected Fellow of the American Statistical Association 2021 Gilbert S. Omenn Computational Proteomics Award NSF CAREER award Chan-Zuckerberg Essential Open-source Software award Senior Member, International Society for Computational Biology

• Statistical Science
• Machine Learning
• Mass Spectrometry
• +5 more

Seraphine V. Wegner is a Full Professor at the Institute of Physiological Chemistry and Pathobiochemistry within the Medical Faculty of the University of Münster. She leads an active research group focused on the spatiotemporal control of cell-material and cell-cell interactions using visible light. Her work bridges synthetic biology, cell biology, and photochemistry to create innovative approaches for tissue engineering and minimal cellular systems. Dr. Wegner's educational background includes a PhD from the University of Chicago (2005-2010) and undergraduate studies at Middle East Technical University in Turkey (2002-2005). Her career path has taken her through prestigious institutions including the Max Planck Institutes in Mainz and Heidelberg, where she established her independent research before joining the University of Münster as a Full Professor in 2019. Her research spans several interconnected areas including light-controlled minimal cellular systems, photoswitchable cell-cell interactions for tissue engineering, light-controlled cell-material interactions, and engineering designer biofilms with light. These research themes share a common thread of using light as a non-invasive tool to precisely control biological processes with high spatial and temporal resolution. Dr. Wegner's publication record shows consistent high-impact output across leading journals in cell biology, synthetic biology, and materials science. Her recent work demonstrates increasing sophistication in multi-color light control systems and applications in both fundamental biological questions and potential therapeutic approaches. ERC Consolidator Grant (2024): LIGHTHOUSE - Light as a signal for nonchemical cell-to-cell communication ERC Starting Grant (2018): ARTIST - Artificial cell-cell interactions for light switchable cell organization and signaling Young Leaders in Science Program, Schering Foundation (2016) MaxSynBio Independent Group Leader, BMBF/MPG (2015) Her research group actively collaborates across disciplines, with projects spanning from fundamental biophysics of cell adhesion to potential medical applications in tissue engineering and bacterial therapeutics. Dr. Wegner has established herself as a leader in the emerging field of optogenetic control of multicellular systems.

• Synthetic Biology
• Cell Biology
• Photochemistry
• +5 more

Dr. Zhen Li is an Assistant Professor in the Department of Mechanical Engineering at Clemson University's College of Engineering, Computing and Applied Sciences. He joined Clemson in August 2019 after serving as a research associate professor at Brown University and a postdoctoral research associate at University of California, Merced. Education: Ph.D. in Fluid Mechanics, Shanghai University, 2012 MS in Fluid Mechanics, Shanghai University, 2008 BS in Engineering Mechanics, Wuhan University, 2005 Dr. Li's research focuses on multiscale modeling of soft matter, complex fluids, biophysics, and collective dynamics using both bottom-up (coarse-grained molecular modeling) and top-down (from continuum descriptions to fluctuating hydrodynamics) approaches, along with high-performance computing. His work spans mathematical theory for coarse-graining and model reduction, statistical methods and machine-learning approaches applied to multiscale modeling, memory effects in complex fluids, and concurrent coupling of heterogeneous solvers for scale-bridging. Analysis of Dr. Li's recent publications reveals a strong trend toward integrating machine learning with traditional computational methods, particularly neural operators for multiscale problems. His work spans diverse applications from bubble dynamics and blood flow to materials science and bioprinting, demonstrating the versatility of his computational approaches across multiple disciplines in engineering and physics. Awards and Recognition: CECAS Dean's Professor Award (2024) Award of Excellence - Junior Faculty (2021-2022) Best Research Poster Award at SC19 (2019) 2nd Place Award of Best Poster Presentation at DOE/EFRC AIM for Composites meeting (2024) Dr. Li actively mentors PhD students including Miles Lu, Ryan Wan, Haizhou Wen, and Ali Mohammadi, who have published significant research in computational mechanics. His research is supported by multiple grants including an NSF Elements grant as PI for 'SciMem: Enabling High Performance Multi-Scale Simulation on Big Memory Platforms', an NSF CDS&E grant as co-PI for 'HAM3R: Heterogeneous Automated Management of Multiscale Methods and Resources', a DOE/EFRC grant as Thrust lead co-PI for 'AIM for Composites', and a NASA EPSCoR grant as Science-PI. Dr. Li leads the MuthComp (Multiscale theory and Computation) research group, which focuses on developing interfaces between Engineering, Applied Mathematics, Physics-based Machine Learning, and High Performance Scientific Computing. The group has active collaborations with institutions including Idaho National Laboratory, University of Tokyo, and Brown University, and has developed open-source software including USERMESO for GPU-accelerated DPD simulations.

• Multiscale/Multiphysics modeling
• Soft matter and Smart materials
• Biophysics and Collective dynamics
• +7 more

Quim Peña is a postdoctoral researcher at the Department of Experimental Molecular Imaging (RWTH Aachen University). He obtained his PhD in Chemistry from Universitat Autònoma de Barcelona (Spain) and Aix-Marseille Université (France) in 2019, focusing on metal-based chemotherapeutics. Current research focuses on nanomedicine for enhanced drug delivery in cancer therapies Specializes in polymeric micelles and prodrug synthesis Recent work involves RGD-coated microbubbles and ultrasound-mediated delivery Contributed to 89Zr-radiolabeled micelle development for personalized breast cancer treatment His publications (2021-2025) emphasize polymer-drug conjugates , multidrug delivery systems , and theranostic applications . Collaborative projects include collaborations with Twan Lammers, Fabian Kiessling, and Josbert Metselaar. 2025: Hydrophobic ion pairing for micelle drug co-loading 2025: Multidrug micelles for brain tumor treatment 2024: RGD-coated microbubbles for blood-brain barrier delivery 2023: Transformative materials for interfacial drug delivery Scientific recognition includes the 2025 CRS Award for best short talk . His work targets cancer nanomedicine with emphasis on side-effect reduction through advanced delivery systems.

• Nanomedicine
• Cancer Therapy
• Metal-Based Chemotherapeutics
• +3 more

Xiangyun Qiu serves as an Associate Professor in the Department of Physics at George Washington University, where she leads the Qiu Lab located in Science & Engineering Hall, Room 6510, Washington DC. Her research bridges physics and biology through molecular-level investigations of biomolecules, utilizing x-ray and neutron scattering, force measurements, and computational modeling. The lab actively explores nucleic acids, proteins, lipids, and emerging medical physics applications including lattice radiotherapy for breast cancer. Her educational foundation includes: PhD in Condensed Matter Physics, Michigan State University (2004) BS in Physics, University of Science and Technology of China (1999) Dr. Qiu's research program centers on developing physical models refined through experimental validation to understand biomolecular systems. Her expertise spans Molecular Biophysics, Medical Physics, and Nucleic Acids Biophysics, with recent expansion into radiation oncology applications. The lab emphasizes bottom-up approaches starting from molecular components to build understanding of complex biological phenomena, particularly focusing on electrostatic interactions in DNA systems and neural tissue engineering. Analysis of her 15 most recent publications (2025-2015) reveals three dominant research trajectories: (1) Cation-mediated DNA-DNA interactions and condensation mechanisms using scattering techniques, (2) Deep learning integration with physics-based modeling for RNA secondary structure prediction, and (3) Translational medical physics applications in cancer therapy. These themes demonstrate consistent synergy between computational biophysics and experimental validation across nucleic acid biophysics, biomaterials development, and clinical radiation physics. The Qiu Lab operates as an interdisciplinary research unit combining experimental scattering facilities with computational modeling capabilities. Current projects include nerve regeneration nanofiber development, conductive hydrogels for neural interfaces, and dosimetric studies for GammaPod radiotherapy systems. The lab's methodology integrates fundamental biophysical principles with practical biomedical applications, maintaining strong connections between molecular-scale phenomena and clinical outcomes.

• Molecular Biophysics
• Medical Physics
• Nucleic Acids Biophysics
• +3 more

Savaş Taşoğlu , an Associate Professor in Mechanical Engineering at Koç University, specializes in interdisciplinary research bridging biomedical engineering and advanced manufacturing. His work integrates microfluidics, tissue engineering, and machine learning to develop transformative diagnostic and therapeutic platforms. Education: PhD (University of California, 2011), MSc (Koç University, 2008), BS (Middle East Technical University, 2006) Postdoctoral: Harvard Medical School (2014) Research focuses on point-of-care diagnostics , bioprinting , magnetic levitation , and microneedle technologies . His lab develops microfluidic contact lenses, multiplex biosensors, and wearable devices for real-time health monitoring. Recent publications emphasize machine learning integration with microfluidics, AI-driven diagnostics , and 3D-printed biomedical devices . He received the Tubitak Incentive Award (2023) for his contributions to biomedical engineering.

• Tissue Engineering
• Fluid Mechanics
• Point-of-care diagnostics
• +5 more

João F. Mano is a Full Professor at the Department of Chemistry , University of Aveiro , Portugal, with additional appointments as Invited Professor at the University of Lorraine (France), Visiting Professor at KAIST (South Korea), and Adjunct Professor at Ajou University (South Korea). He serves as Vice-Director of the CICECO – Aveiro Institute of Materials and leads the COMPASS Research Group , focusing on advanced biomaterials , regenerative medicine , and 3D bioprinting for biomedical applications. PhD in Chemistry (1996, Technical University of Lisbon) D.Sc. in Tissue Engineering, Regenerative Medicine, and Stem Cells (2012, University of Minho) His research spans bio-inspired materials , cell and tissue engineering , and nanomicro platforms for biomedicine , integrating polymer science , biomimetic approaches , and cell-microenvironment interactions to develop biomedical devices and disease models for drug screening. The 15 most recent publications highlight innovations in 3D bioprinting ( Advanced Materials , Biomaterials ), hydrogels ( Advanced Healthcare Materials ), microenvironment engineering ( Small ), and multi-scale tissue constructs ( Advanced Science ). His work emphasizes personalized medicine , biofabrication , and smart biomaterials . Scientific Honors include: ERC Advanced Grant (2015, 2020) European Academy of Sciences Fellow (FEurASc) Doctor Honoris Causa (University of Lorraine, 2019; University of Utrecht, 2022) George Winter Award (2020) FAIMBE Fellow (2022) He has supervised 74+ MSc , 26 PhD , and 40+ post-doctoral fellows , co-founded METATISSUE and CELLULARIS Biomodels , and holds 12 patents (8 as senior inventor). His editorial roles include Materials Today Bio (Elsevier) and leadership in major EU research projects like TissueEng , REBORN , and O2CELLS .

• Biomaterials
• Tissue Engineering
• Regenerative Medicine
• +6 more

Professor Philipp Seib is a Visiting Professor at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, and a SULSA (Scottish Universities Life Science Alliance) Visiting Professor. His research spans the nano- to macro scale with a focus on biomaterials, particularly silk, for applications in drug and cell delivery. Professor Seib's research program integrates fundamental biomaterials science with translational applications. His work can be divided into bottom-up, curiosity-driven research and top-down, challenge-based activities: Silk-based drug delivery systems for tissue engineering and therapeutic applications Advanced drug delivery systems and cellular responses to nanomedicines Engineering cellular microenvironments for stem and cancer cells Development of three-dimensional culture systems mimicking native tissue environments Engineering artificial in vivo stem cell niches as "traps" for circulating tumor cells His research demonstrates a clear progression from basic biomaterials characterization toward clinical applications, particularly in cancer therapy and regenerative medicine. The integration of silk's remarkable physical properties (tougher than manmade fibers) with advanced drug delivery mechanisms represents a significant contribution to biomaterials science. Professor Seib has received notable recognition for his work: Fellow of The Academy of Pharmaceutical Sciences of Great Britain (2021) Fellow Leibniz Institute of Polymer Research Dresden (2018) Professor Seib actively supervises research and secures competitive funding. He serves as Principal or Co-Investigator on multiple significant projects including NMR-BASE, Establishing cerebral organoids as a human model of stroke, and Multiscale Metrology Suite for Next-generation Healthcare Technologies. His laboratory (www.SeibLab.com) develops silk-based hydrogels, nanoparticles, films, and scaffolds processed under mild aqueous conditions for biomedical applications. The Seib Lab operates at the intersection of biomaterials science, drug delivery, and tissue engineering, with research contributing to UN Sustainable Development Goals related to health and well-being. His fingerprint of research activity shows strong connections to mesenchymal stem cells, drug delivery, bone biology, therapeutic procedures, nanoparticles, and in vitro studies.

• Biomaterials
• Drug Delivery Systems
• Nanomedicine
• +5 more

Quinn P. Peterson, Ph.D. , is an Assistant Professor of Physiology at Mayo Clinic in Rochester, Minnesota. He holds dual administrative appointments as Senior Associate Consultant I-Research in the Department of Physiology & Biomedical Engineering and in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition within the Department of Internal Medicine. His research is centered at the intersection of regenerative medicine and diabetes therapy. Institution: Mayo Clinic School: College of Medicine and Science Department: Department of Physiology & Biomedical Engineering Research Center: Center for Regenerative Biotherapeutics Dr. Peterson earned his Ph.D. in Biochemistry from the University of Illinois Urbana-Champaign and completed a prestigious postdoctoral fellowship at Harvard University, supported by the Juvenile Diabetes Research Foundation (JDRF). He is a former member of the NIH’s Human Islet Research Network (2014–2017). His research focuses on building human islets as a cell replacement therapy for type 1 diabetes. Key areas include: Directed differentiation of stem cells into pancreatic alpha and beta cells Bottom-up engineering of functional islet organoids Small molecule screening for novel diabetes therapeutics Transplantation studies to develop clinical cell therapies His publication record includes high-impact studies in Cell , Nature , Nature Medicine , and Nature Communications . These works demonstrate a consistent trajectory toward understanding and engineering functional human islet cells, with implications for both type 1 and type 2 diabetes treatment. His recent work expands into regulatory science, cryopreservation, and microfluidic platforms for stem cell applications. Scientific awards and recognitions include: JDRF Postdoctoral Fellowship (2011–2014) Biochemistry Trust of Urbana Award, University of Illinois (2013) Member, Human Islet Research Network, NIH (2014–2017) Dr. Peterson leads an active research lab contributing to drug discovery, islet regeneration, and translational regenerative biotherapeutics. His work is supported by institutional and collaborative grants, though specific funding details are not listed. He collaborates extensively with leaders in stem cell and diabetes research, including Douglas Melton’s group at Harvard. He is involved in clinical trial research and postdoctoral training programs at Mayo Clinic, contributing to the development of future scientists in regenerative medicine. His lab is part of the Center for Regenerative Biotherapeutics’ Islet Regeneration Program, where multidisciplinary teams work on advancing stem cell-derived islets toward clinical application. The lab leverages 3D culture systems, tissue engineering, and functional screening platforms to develop scalable and transplantable islet cell products.

• Regenerative Medicine
• Stem Cell Biology
• Diabetes Research
• +7 more

Marianne Ellis is a Professor in the Department of Chemical Engineering at the University of Bath, serving as Head of Department (2019–2023) and former Associate Dean of Learning & Teaching (2016–2019). Her research focuses on bioprocess design for tissue engineering applications, including cellular agriculture, drug discovery in vitro models (e.g., bioartificial livers, organoids), and cell therapy bioprocessing. She leads projects funded by EPSRC, EU Horizon 2020, and industry collaborations, such as the Cellular Agriculture Manufacturing Hub. Research interests emphasize scaling non-animal technologies and bioreactor development. Key projects include cultured meat production life cycle assessments, fluidized bed bioreactor optimization for erythroid cells, and plant-based scaffolds for bone tissue engineering. She co-directs Cellesce Ltd, advancing cell therapy and organoid technologies. Ellis contributes to UN Sustainable Development Goals related to sustainable food systems and climate action. Her articles highlight advancements in bioreactor engineering, organoid expansion, and sustainable bioprocessing. Research outputs span peer-reviewed journals and conferences, with notable work in Science of the Total Environment and Nature Food . Ellis actively supervises doctoral students and mentors in cellular agriculture and bioengineering.

• Cellular Agriculture Bioprocessing
• Drug Discovery (In Vitro Models)
• Cell Therapy Bioprocessing
• +5 more

Professor Jennifer McManus serves as Professor and Head of School of Physics at the University of Bristol, where she leads research at the intersection of physics, biology, and chemistry. With a BSc and PhD, she has established herself as a prominent figure in soft matter physics and biological physics, particularly in protein science. She also holds a position as Visiting Associate Professor at University College Dublin's School of Chemical and Bioprocess Engineering since September 2020. Her research focuses on how proteins, peptides, and other macromolecules assemble into condensed phases such as crystals, amorphous aggregates, gels, and fibers. She investigates how inter-molecular protein-protein interactions relate to assembly processes, with particular interest in how anisotropic protein-protein interactions direct protein assembly. Her work utilizes protein phase diagrams to measure and understand this behavior, while also exploring the rational design of protein-based materials, mechanical properties of protein gels and tissues, and protein formulation and stability. Analysis of her 43 research outputs reveals a strong focus on liquid-liquid phase separation of proteins, membrane protein crystallization, and peptide assembly. Her recent work (2023-2025) demonstrates leadership in de novo protein design, particularly in creating membraneless organelles and understanding phase separation phenomena. Her research bridges fundamental biophysics with potential applications in synthetic biology and therapeutic development. BBSRC International Institutional Award 2022 (Principal Investigator, Nov 2022-Mar 2023) RAMP - Marie Curie ITN Project (Principal Investigator, Oct 2020-Aug 2021) Professor McManus leads the Quantum & Soft Matter research group at Bristol, with research themes spanning Soft Matter, Biological Physics, Protein and Peptide Self-Assembly, Bottom-up Synthetic Biology, Cavitation, and Rheology. Her fingerprint analysis shows strong activity in Solution and Solubility (100%), Crystallin (54%), Lipid (35%), and Phase Separation (25%) research areas. Her work has generated significant interest with multiple datasets hosted on Zenodo related to membraneless organelle assembly and has been disseminated through 36 journal articles, 4 book chapters, and other scholarly outputs.

• Soft Matter
• Biological Physics
• Protein and Peptide Self-Assembly
• +6 more

Prof. Seraphine Wegner is a Full Professor at the Institute of Physiological Chemistry and Pathobiochemistry within the Faculty of Medicine at the University of Münster. Her research focuses on developing light-controlled systems for precise spatiotemporal manipulation of cellular processes, with applications in synthetic biology, tissue engineering, and cell-material interactions. Dr. Wegner received her PhD in Chemistry from the University of Chicago (2005-2010), followed by postdoctoral training at the Max Planck Institute for Intelligent Systems and the University of Heidelberg (2011-2015). She served as an Independent Group Leader at the Max Planck Institute for Polymer Research (2016-2020) before joining the University of Münster as a Full Professor in 2019. Her research program centers on the spatiotemporal control of cell-material and cell-cell interactions using visible light. This innovative approach enables non-invasive remote control over cell adhesions, self-assembly of cells into multicellular architectures, regulation of interactions with synthetic materials, and the study of underlying biological processes. Her work bridges multiple disciplines including synthetic biology, optogenetics, and tissue engineering, with specific focus areas on light-controlled minimal cellular systems, photoswitchable cell-cell interactions, and engineering designer biofilms with light. Analysis of her recent publications reveals a strong focus on light-controlled synthetic biology, with particular emphasis on developing tools for precise spatial and temporal control of cellular behaviors. Her work spans from fundamental studies of cell adhesion and motility to applications in tissue engineering and synthetic cell communities, demonstrating consistent innovation in using light as a non-invasive control mechanism for cellular processes. ERC Consolidator Grant (2024) for 'LIGHTHOUSE - Light as a signal for nonchemical cell-to-cell communication' ERC Starting Grant (2018) for 'ARTIST - Artificial cell-cell interactions for light switchable cell organization' Young Leaders in Science Program (2016) by the Schering Foundation MaxSynBio Independent Group Leader position (2015) Alexander von Humboldt Postdoctoral Fellowship (2012) Prof. Wegner actively mentors numerous PhD students and postdoctoral researchers in her lab at the University of Münster. Her research is supported by multiple grants including ERC funding and foundation support. She has established a strong research program that bridges synthetic biology, cell biology, and materials science, with applications in tissue engineering and synthetic cell communities. The Wegner Lab at the University of Münster comprises a multidisciplinary team of postdoctoral researchers, PhD students, and technical staff working at the intersection of cell biology, synthetic biology, and materials science. The lab maintains strong collaborations with the Max Planck Society and participates in research networks such as CRC 1348, focusing on developing light-controlled systems for engineering synthetic cells and multicellular architectures with precise spatial and temporal control.

• Cell Biology
• Molecular Biology
• Biochemistry
• +6 more

Laura Elise de Heus is a Researcher at the Applied Stem Cell Technologies group within the TechMed Centre at the University of Twente, specializing in advanced tissue engineering models and vascular biology. Her work integrates immunology with micro-engineering to develop physiologically relevant systems for disease modeling. Her primary research interests span Tissue Engineering , Vascular Biology , and Macrophage Biology , with specific focus on organ-on-chip technology and biomaterial development. She investigates how embedded macrophages trigger intravascular coagulation in 3D blood vessel models, addressing critical gaps in understanding vascular inflammation and thrombosis mechanisms. Analysis of her 2019-2024 publications reveals a clear research trajectory: initial work on poly(lactic acid) micro-objects for tissue scaffolding evolved into sophisticated vascular inflammation models incorporating immune cells. This progression demonstrates her contribution to advancing in vitro vascular disease modeling through engineering-immunology integration. Dr. de Heus operates within the Applied Stem Cell Technologies research group at the TechMed Centre, a multidisciplinary institute fostering collaboration between engineering, medicine, and life sciences. Her work exemplifies the center's mission to develop innovative medical technologies through cross-disciplinary approaches.

• Tissue Engineering
• Vascular Biology
• Macrophage Biology
• +3 more

Alexander Mason is a DECRA Fellow at the University of Wollongong, leading the Synthetic Biomimetic Compartments research group. His work focuses on bottom-up synthetic cell design, integrating polymer chemistry, membrane engineering, and open-source hardware solutions like the DIB-BOT droplet interface bilayer robot. Mason holds a PhD and BSc in Nanotechnology from UNSW Sydney, with postdoctoral experience at Eindhoven University of Technology and UNSW. Educations: PhD in Chemistry, UNSW Sydney, 2017 BSc in Nanotechnology, UNSW Sydney, 2012 His research interests span synthetic cells, biomimetic compartments, and stochasticity in biological systems. Key projects include the DECRA-funded 'Building a synthetic chemical synapse through harnessed stochasticity' (2023–2027), exploring molecular fluctuations' impact on higher-order biological phenomena. Publications emphasize droplet-based systems (e.g., DIB-BOT), polymer vesicle engineering, and synthetic cell applications in tissue engineering. Notable recognition includes the 2023 ASB Best ECR Talk Award for his DIB-BOT work. Current supervision includes PhD projects on synthetic chemical synapses and neural progenitor cell guidance systems. The lab also develops DIY hardware solutions and collaborates on interdisciplinary biomaterials projects.

• Synthetic Biology
• Self-Assembly
• Polymer Chemistry
• +3 more